- Report
- January 2025
- 300 Pages
Global
From €4492EUR$4,950USD£3,787GBP
- Report
- December 2024
- 263 Pages
Global
From €4492EUR$4,950USD£3,787GBP
- Report
- September 2024
- 291 Pages
Global
From €4492EUR$4,950USD£3,787GBP
- Report
- November 2024
- 239 Pages
Global
From €3789EUR$4,175USD£3,194GBP
- Report
- March 2025
- 130 Pages
Global
From €2995EUR$3,300USD£2,525GBP
- Report
- May 2025
- 189 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 116 Pages
Global
From €4220EUR$4,650USD£3,558GBP
- Report
- May 2025
- 124 Pages
Global
From €4220EUR$4,650USD£3,558GBP
- Drug Pipelines
- May 2025
- 150 Pages
Global
From €2995EUR$3,300USD£2,525GBP
- Report
- May 2025
- 170 Pages
Global
From €4220EUR$4,650USD£3,558GBP
- Report
- April 2025
- 162 Pages
Global
From €4220EUR$4,650USD£3,558GBP
- Report
- April 2025
- 388 Pages
Global
From €4220EUR$4,650USD£3,558GBP
- Report
- March 2025
- 219 Pages
Global
From €4220EUR$4,650USD£3,558GBP
- Report
- November 2024
- 207 Pages
Global
From €4220EUR$4,650USD£3,558GBP
- Report
- March 2025
- 120 Pages
Global
From €4447EUR$4,900USD£3,749GBP
- Report
- May 2025
- 193 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 187 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- October 2024
- 195 Pages
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 191 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP
- Report
- May 2025
- 192 Pages
Global
From €3217EUR$3,545USD£2,712GBP
€3575EUR$3,939USD£3,014GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more